Uncovering news and insights
We’re constantly working to unlock new ideas that can drive progress. Here you’ll find research, data analysis, and expert perspectives to help you create better outcomes for your people.
Keeping medication costs manageable in a year of economic pressures
Despite inflation and price hikes across many commonly used drugs, the employer-sponsored insurance market continues to deliver meaningful stability – and even savings – thanks to strong cost management strategies.
Here are three ways plan sponsors can promote and manage the appropriate use of biosimilars to improve drug affordability and access for members.
Plan sponsors are overlooking simple strategies to increase specialty medication adherence.
All too often, a person’s gender, race, education, income or zip code dictates how healthy they are.
To help clients prepare for the wave of biosimilars on the horizon, we answer some basic questions about these potentially game-changing medications.
The advancements that will accelerate the delivery of proper treatment, reduce administrative burden, and improve the overall care experience for patients and providers.
COVID-19 and other recent events have likely exacerbated stress and depression among teenagers in the United States, who already struggle with mental health stigmas and access to medications and therapies.
